Cellebrite DI Ltd.NASDAQ: CLBT

CLBT FY26 Q3 Historical Financial Tables and Supplemental Data

· Issued by Cellebrite DI Ltd.

Summary by 6ix AI

Cellebrite DI Ltd. published unaudited financial tables for the third quarter ended September 30, 2026, showing total revenue of US$149,022 thousand and net income of US$26,656 thousand under US accounting rules (GAAP), or US$0.10 per diluted share.

Key details

  • Subscription revenue for the third quarter ended September 30, 2026 totalled US$134,905 thousand. By region, revenue was US$81,307 thousand from the Americas, US$47,823 thousand from EMEA (Europe, Middle East and Africa) and US$19,892 thousand from APAC (Asia-Pacific).
  • On a non-GAAP basis, which excludes items such as share-based compensation, amortization of intangible assets and acquisition-related costs, third-quarter net income was US$45,550 thousand, or US$0.17 per diluted share. Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization, with those adjustments) was US$53,625 thousand, a 36.0% margin.
  • Annual recurring revenue (the yearly value of recurring revenue) was US$528,452 thousand for the quarter ended September 30, 2026, and the recurring revenue net dollar-based retention rate, which tracks revenue kept and grown from existing customers, was 116%.
  • Third-quarter net cash from operating activities was US$56,581 thousand and free cash flow (operating cash flow minus capital expenditures) was US$51,797 thousand. Cash and cash equivalents and restricted cash were US$223,055 thousand at the end of the period.
  • For the nine months ended September 30, 2026, total revenue was US$408,461 thousand and GAAP net income was US$43,965 thousand, or US$0.17 per diluted share.

6ix AI wrote this summary from the release below and checked it against the release.

Investor Kit Third Quarter 2026

Cellebrite DI Ltd. Condensed and Consolidated - US GAAP Income Statements

(U.S. Dollars in thousands, except share and per share data - unaudited)

Yr Ended

31-Dec

$ 271,028

82,007

353,035

17,285

30,883

401,203

26,004

-16,200

20,389

62,593

338,610

98,415

132,389

50,900

-

281,704

56,906

(332,890)

(275,984)

7,023

$ (283,007)

$ (1.35)

$ (1.35)

209,471,827

209,471,827

84.4%

24.5%

33.0%

12.7%

70.2%

14.2%

-2.5%

-70.5%

FY 2023 FY 2024

FY 2025

Yr Ended

31-Dec

$ 330,765

96,245

427,010

17,771

30,894

475,675

37,461

87

15,617

22,007

75,172

400,503

113,877

154,814

65,332

-

334,023

66,480

24,198

90,678

12,352

$ 78,326

$ 0.32

$ 0.31

241,626,316

249,903,126

84.2%

23.9%

32.5%

13.7%

70.2%

14.0%

13.6%

16.5%

Quarter Ended 31-Mar 30-Jun 30-Sep 31-Dec

FY 2026

YTD

30-Sep

$ 295,397

76,851

372,248

14,005

22,208

408,461

-

43,017

3,490

13,450

15,645

75,602

-332,859

108,220

123,806

57,890

-

289,916

42,943

13,619

56,562

12,597

$ 43,965

$ 0.18

$ 0.17

247,865,510

253,087,365

81.5%

26.5%

30.3%

14.2%

71.0%

10.5%

22.3%

10.8%

Quarter Ended 31-Mar 30-Jun 30-Sep

Revenue:

Subscription services

$ 76,688 $

80,814

$ 84,195 $

89,068

$ 96,549

$ 97,685

$ 101,163

Term-license Total subscription

Other non-recurring*

Professional services

Total revenue

Cost of revenue: Subscription services Term-license

Other non-recurring* Professional services

Total cost of revenue

Gross profit

Operating expenses: Research and development Sales and marketing General and administrative Other

Total operating expenses Operating income (loss) Financial income (expense), net

Income (loss) before taxes on income

Tax expense (income)

19,141 22,147 28,531 26,426

95,829 102,961 112,726 115,494

4,411 3,292 5,504 4,564

7,309 7,023 7,799 8,763

107,549 113,276 126,029 128,821

8,432 8,522 10,005 10,502

- - - 87

3,301 3,198 4,791 4,327

5,757 5,957 5,518 4,775

17,490 17,677 20,314 19,691

90,059 95,599 105,715 109,130

27,277 28,611 28,124 29,865

38,768 38,685 38,800 38,561

11,746 13,886 19,801 19,899

- - - -

77,791 81,182 86,725 88,325

12,268 14,417 18,990 20,805

7,060 6,374 5,298 5,466

19,328 20,791 24,288 26,271

1,928 1,315 4,099 5,010

21,304 21,805 33,742

117,853 119,490 134,905

3,668 3,912 6,425

6,780 7,736 7,692

128,301 131,138 149,022

- - -

13,439 14,627 14,951

799 1,354 1,337

3,497 3,764 6,189

4,685 5,462 5,498

22,420 25,207 27,975

105,881 105,931 121,047

35,872 35,961 36,387

43,222 43,753 36,831

17,668 19,268 20,954

- - -

96,762 98,982 94,172

9,119 6,949 26,875

4,515 4,238 4,866

13,634 11,187 31,741

2,696 4,816 5,085

Net Income (loss)

Basic net earnings (loss) per share Diluted net earnings (loss) per share

$ 17,400

$ 0.07

$ 0.07

$ 19,476

$ 0.08

$ 0.08

$ 20,189

$ 0.08

$ 0.08

$ 21,261

$ 0.09

$ 0.08

$ 10,938

$ 0.04

$ 0.04

$ 6,371

$ 0.03

$ 0.02

$ 26,656

$ 0.11

$ 0.10

Yr Ended

31-Dec

$ 209,751

70,663

280,414

13,561

31,135

325,110

19,219

6

13,766

20,240

53,231

271,879

84,386

110,813

43,443

-

238,642

33,237

(108,800)

(75,563)

5,537

$ (81,100)

$ (0.42)

$ (0.43)

190,154,549

190,154,549

83.6%

26.0%

34.1%

13.4%

73.4%

10.2%

-7.3%

-24.9%

Pro-forma weighted average number of shares used to compute basic net earnings per share Pro-forma weighted average number of shares used to compute diluted net earnings per share

Gross margin

R&D % of total revenue S&M % of total revenue G&A % of total revenue

Total Operating Expenses % of total revenues

Operating margin Tax rate

Net margin

Note: This document should be read in conjunction with the Company's SEC Filings.

*Other non-recurring revenue is composed of hardware sales, usage fees and perpetual licenses, and was previously referred

237,246,654 240,358,573 243,508,803 245,282,244

249,302,220 248,980,462 249,719,713 251,501,118

83.7% 84.4% 83.9% 84.7%

25.4% 25.3% 22.3% 23.2%

36.0% 34.2% 30.8% 29.9%

10.9% 12.3% 15.7% 15.4%

72.3% 71.7% 68.8% 68.6%

11.4% 12.7% 15.1% 16.2%

10.0% 6.3% 16.9% 19.1%

16.2% 17.2% 16.0% 16.5%

246,470,084 247,617,591 249,475,824

252,077,487 252,788,652 254,362,925

82.5% 80.8% 81.2%

28.0% 27.4% 24.4%

33.7% 33.4% 24.7%

13.8% 14.7% 14.1%

75.4% 75.5% 63.2%

7.1% 5.3% 18.0%

19.8% 43.0% 16.0%

8.5% 4.9% 17.9%

FY 2026

Quarter Ended

Quarter Ended

31-Mar 30-Jun 30-Sep 31-Dec 31-Mar 30-Jun 30-Sep

$ 76,688

19,141

95,829

4,411

$ 80,814 $ 84,195

22,147 28,531

102,961 112,726

3,292 5,504

$ 89,068

26,426

115,494

4,564

$

96,549

$

97,685

7,309 7,023 7,799 8,763

107,549 113,276 126,029 128,821

21,304

117,853

3,668

6,780

128,301

$ 101,163

21,805 33,742

119,490 134,905

3,912 6,425

7,736 7,692

131,138 149,022

8,113

-3,044

8,143

-2,943

9,361

-5,095

9,115

87

4,243

5,583 5,764 5,030 4,590

16,740 16,850 19,486 18,035

9,438

799

3,423

4,456

18,116

8,738 8,630

1,354 1,337

3,690 6,098

5,231 5,267

19,013 21,332

90,809

96,426

106,543

110,786

110,185

112,125

127,690

24,198

35,694

25,388

35,281

24,762

35,136

25,800

34,638

8,946 9,533 10,675 13,850

68,838 70,202 70,573 74,288 21,971 26,224 35,970 36,498

7,060 6,374 5,298 5,466

29,031 32,598 41,268 41,964

1,928 1,315 4,099 5,010

(924) (510) (309) (260)

- - - -

- - - -

$ 26,179 $ 30,773 $ 36,860 $ 36,694

29,826

39,569

12,204

81,599

28,586

4,515

33,101

2,696

215

-

-

$ 30,620

29,446 29,960

39,955 33,094

12,919 13,106

82,320 76,160 29,805 51,530

4,238 4,866

34,043 56,396

4,816 5,085

465 (5,761)

- -

- -

$ 29,692 $ 45,550

FY 2025

FY 2024

FY 2023

Yr Ended

31-Dec

$ 209,751

70,663

280,414

13,561

31,135

325,110

19,219

6

13,644

18,577

51,446

273,664

77,866

102,842

37,674

218,382

55,282

(108,800)

(53,518)

5,537

633

-119,348

$ 60,926

$ 0.31

$ 0.28

190,154,549

206,194,081

84.2%

24.0%

31.6%

11.6%

67.2%

17.0%

-9.2%

18.7%

Yr Ended

31-Dec

$ 271,028

82,007

353,035

17,285

30,883

401,203

26,004

-16,047

18,313

60,364

340,839

88,648

121,752

38,320

248,720

92,119

(332,890)

(240,771)

7,023

(4,049)

-349,604

$ 97,761

$ 0.45

$ 0.42

209,471,827

227,258,731

85.0%

22.1%

30.3%

9.6%

62.0%

23.0%

-1.2%

24.4%

Yr Ended

31-Dec

$ 330,765

96,245

427,010

17,771

30,894

475,675

34,732

87

15,325

20,967

71,111

404,564

100,148

140,749

43,004

283,901

120,663

24,198

144,861

12,352

(2,003)

-

-

$ 130,506

$ 0.54

$ 0.51

241,626,316

254,677,860

85.1%

21.1%

29.6%

9.0%

59.7%

25.4%

7.1%

27.4%

YTD

30-Sep

$ 295,397

76,851

372,248

14,005

22,208

408,461

26,806

3,490

13,211

14,954

58,461

350,000

89,232

112,618

38,229

240,079

109,921

13,619

123,540

12,597

(5,081)

-

-

$ 105,862

$ 0.42

$ 0.40

247,865,510

259,774,704

85.7%

21.8%

27.6%

9.4%

58.8%

26.9%

6.1%

25.9%

Cellebrite DI Ltd. Condensed and Consolidated - Non-GAAP Income Statements

(U.S. Dollars in thousands, except share and per share data - unaudited)

Revenue:

Subscription services Term-license

Total subscription Other non-recurring* Professional services

Total revenue

Cost of revenue: Subscription services Term-license

Other non-recurring* Professional services

Total cost of revenue

Gross profit

Operating expenses: Research and development Sales and marketing General and administrative

Total operating expenses Non-GAAP operating income Financial Income, net

Income (loss) before taxes on income

Tax expense (income) Income tax adjustment One time tax income Finance expense (income) Non-GAAP net income

Basic net earnings (loss) per share Diluted net earnings per share

$ 0.11 $

$ 0.10 $

0.13 $

0.12 $

0.15 $

0.14 $

0.15

0.14

$ 0.12 $

$ 0.12 $

0.12 $

0.11 $

0.18

0.17

Pro-forma weighted average number of shares used to compute basic net earnings per share Pro-forma weighted average number of shares used to compute diluted net earnings per share

Gross margin

R&D % of total revenue S&M % of total revenue G&A % of total revenue

Total Operating Expenses % of total revenues

Operating margin Tax rate

Net margin

Note: This document should be read in conjunction with the Company's SEC Filings.

237,246,654 240,358,573 243,508,803 245,282,244

252,456,562 252,713,944 256,157,437 257,274,507

84.4% 85.1% 84.5% 86.0%

22.5% 22.4% 19.6% 20.0%

33.2% 31.1% 27.9% 26.9%

8.3% 8.4% 8.5% 10.8%

64.0% 62.0% 56.0% 57.7%

20.4% 23.2% 28.5% 28.3%

3.5% 2.5% 9.2% 11.3%

24.3% 27.2% 29.2% 28.5%

246,470,084 247,617,591 249,475,824

259,252,345 259,522,205 260,516,532

85.9% 85.5% 85.7%

23.2% 22.5% 20.1%

30.8% 30.5% 22.2%

9.5% 9.9% 8.8%

63.6% 62.8% 51.1%

22.3% 22.7% 34.6%

8.8% 15.5% -1.2%

23.9% 22.6% 30.6%

*Other non-recurring revenue is composed of hardware sales, usage fees and perpetual licenses, and was previously referred to "Perpetual license and other." Changing the name for this type of revenue reflects that perpetual license revenue has declined to relatively insignificant levels with hardware sales now representing the majority of this type of revenue.

FY 2025

FY 2024

FY 2023

Cellebrite DI Ltd. Condensed and Consolidated - Balance Sheets

(U.S. Dollars in thousands)

ASSETS

Current Assets

Quarter Ended

31-Mar 30-Jun 30-Sep

Quarter Ended

FY 2026

Yr Ended 31-Dec

$ 124,457

161,049

151,544

104,972

19,630

6,595

7,603

575,850

14,618

97,959

10,880

22,209

81,469

16,308

119,559

363,002

$ 938,852

$ 16,834

71,244

277,583

3,996

369,657

16,677

49,526

-

-

-18,674

84,877

$ 454,534

* -568,721

(85)

2,220

(86,538)

484,318

938,852

31-Mar 30-Jun 30-Sep

Cash and cash equivalents

$ 90,475

$ 179,223

$ 281,361

$ 133,689

$ 141,250

$ 223,055

Short-term deposits Marketable securities Trade receivables

Prepaid expenses and other current assets Contract acquisition costs

Inventories

Total current assets

Non-current assets Other non-current assets Marketable securities Deferred tax assets, net

Property and equipment, net Intangible assets, net

Operating lease right-of-use assets, net Goodwill

Total non-current assets

177,754 146,053 127,216

141,257 146,908 117,135

81,142 93,127 104,196

17,625 23,489 20,812

6,260 7,772 9,034

8,969 9,537 8,648

523,482 606,109 668,402

6,897 6,687 6,289

100,305 85,661 69,580

11,545 12,586 12,727

17,766 19,962 22,533

10,922 10,242 9,807

10,261 17,464 16,267

28,714 28,714 28,714

186,410 181,316 165,917

140,777 146,759 121,207

154,602 154,522 139,607

72,739 110,782 139,816

25,799 21,514 21,375

5,732 6,466 5,844

7,528 8,388 7,509

540,866 589,681 658,413

7,091 7,344 7,803

105,491 103,185 109,410

11,760 11,667 11,791

23,150 24,552 27,431

127,966 121,909 117,928

16,403 16,414 16,151

119,559 119,559 119,559

411,420 404,630 410,073

Total Assets

Liabilities, redeemable convertible preferred shares and shareholders' equity (deficiency)

Current Liabilities

Trade payables

$ 709,892

$ 10,214

$ 787,425

$ 10,587

$ 834,319

$ 11,136

$ 952,286

$ 10,868

$ 994,311

$ 18,113

$ 1,068,486

$ 20,473

Other accounts payable and accrued expenses Deferred revenues

Operating lease liabilities

Total current liabilities

Long-term Liabilities

Other long-term liabilities Long-term deferred revenues

Restricted Sponsor Shares liability Price Adjustment Shares liability Derivative warrant liabilities Operating lease liabilities

Total long-term liabilities

53,932 67,969 62,486

219,442 227,177 239,677

4,210 4,236 3,618

287,798 309,969 316,917

6,566 6,852 7,510

45,641 44,096 44,386

- - -

- - -

- - -

6,393 18,095 17,821

58,600 69,043 69,717

79,652 77,009 73,351

255,095 263,350 295,513

4,596 5,736 6,115

350,211 364,208 395,452

23,179 24,573 25,424

50,147 49,940 51,065

- - -

- - -

- - -

18,209 17,493 17,238

91,535 92,006 93,727

Total Liabilities

Yr Ended 31-Dec

$ 191,659

153,746

101,818

82,358

23,246

5,827

8,939

567,593

7,682

36,601

11,072

16,995

11,306

10,604

28,714

122,974

$ 690,567

$ 11,077

63,330

216,970

4,125

295,502

6,954

45,247

-

-

-6,844

59,045

$ 354,547

* -498,883

(85)

2,086

(164,864)

336,020

$ 690,567

$ 346,398

$ 379,012

$ 386,634

$ 441,746

$ 456,214

$ 489,179

Shareholders' equity (deficiency)

Share capital

Additional paid-in capital

Treasury stock, NIS 0.00001 par value; 41,776 ordinary shares Accumulated other comprehensive income

(Accumulated deficit) Retained earnings Total shareholders' equity (deficiency)

* - * - * -

510,153 533,847 553,111

(85) (85) (85)

890 2,639 2,459

(147,464) (127,988) (107,800)

363,494 408,413 447,685

* - * - * -

585,233 605,809 622,769

(85) (85) (85)

992 1,602 (804)

(75,600) (69,229) (42,573)

510,540 538,097 579,307

Yr Ended 31-Dec

$ 189,517

74,713

38,693

77,269

26,400

5,550

9,940

422,082

7,341

28,859

7,024

15,896

10,594

14,260

26,829

83,974

$ 506,056

$ 8,282

44,845

195,725

4,972

253,824

5,515

47,098

47,247

81,715

54,117

9,157

244,849

$ 498,673

* -(84,896)

(85)

1,050

118,143

34,212

$ 532,885

Total liabilities, redeemable convertible preferred shares and shareho

* Less than US$ 1.

Note: This document should be read in conjunction with the Company's SEC Filings.

$ 709,892

$ 787,425

$ 834,319

$ 952,286

$ 994,311

$ 1,068,486

Yr Ended 31-Dec

$ (81,100)

18,998

(1,106)

10,011

-(7,737)

5,125

34,102

29,715

55,531

2,271

46,114

(5,610)

(9,211)

4,362

(4,196)

-243

3,691

734

121

102,058

(5,231)

(2,687)

(55,317)

56,336

-

-(15,641)

(22,540)

-19,142

2,623

21,765

101,283

589

87,645

$189,517

$ 10,047

$ -

$ -

$ 4,363

$ -

$ -

$ -

Yr Ended 31-Dec

$(283,007)

30,575

(2,904)

10,607

-(10,736)

(4,015)

110,664

65,889

173,051

(5,829)

22,317

(341)

3,201

5,335

(4,839)

-982

2,755

17,586

880

132,171

(8,566)

(2,043)

(127,789)

59,971

-(2,748)

(68,298)

(149,473)

42

17,265

3,344

20,651

3,349

(1,207)

189,517

$ 191,659

$ 7,706

$ -

$ -

$ 1,884

$ 164,770

$ 113,136

$ 254,766

Yr Ended 31-Dec

$ 78,326

44,892

(2,371)

11,867

554

(8,164)

75

-

-

-(15,781)

49,768

(6,936)

5,614

4,585

547

1,760

1,632

4,943

4,248

(2,015)

173,544

(13,225)

-(321,231)

152,992

59,809

(147,456)

861

(268,250)

-20,097

4,956

25,053

(69,653)

2,451

191,659

$ 124,457

$ (549)

$ -

$ -

$ 11,154

$ -

$ -

$ -

FY 2023 FY 2024 FY 2025 FY 2026

Cellebrite DI Ltd. Condensed and Consolidated - Quarterly US GAAP Cash Flows

(U.S. Dollars in thousands - unaudited)

Quarter Ended

31-Mar 30-Jun 30-Sep 31-Dec

Quarter Ended

YTD

30-Sep

$ 43,965

45,079

(2,117)

25,259

0

(5,373)

(695)

-

-

-(34,761)

20,527

(160)

197

3,313

(2,473)

-163

3,467

(4,858)

2,522

94,055

(10,893)

(24,089)

(195,451)

90,222

105,342

(15,278)

45,215

(4,932)

-5,569

4,168

9,737

98,860

(262)

124,457

$223,055

$ 15,157

$ -

$ -

$ 3,156

$ -

$ -

$ -

31-Mar 30-Jun 30-Sep

Cash flows from operating activities:

Net income (loss)

Adjustments to reconcile net income to net cash provided by (used in) operating activities:

$ 17,400 $

19,476

$ 20,189 $

21,261

$ 10,938

$ 6,371

$ 26,656

Share-based compensation and RSU's

Amortization of premium and discount and accrued interest on marketable securities Depreciation and amortization

Disposal and write-off of property and equipment Interest income from short-term deposits Deferred tax assets, net

Revaluation of derivative warrants

Remeasurement of Restricted Sponsor Shares liability Remeasurement of Price Adjustment Shares liability (Increase) decrease in trade receivables

Increase (decrease) in deferred revenue Decrease (increase) in other non-current assets

Decrease (Increase) in prepaid expenses and other current assets Changes in operating lease assets

Changes in operating lease liability

Abandonment of right-of-use assets and disposal of leasehold Improvements (Increase) decrease in inventories

(Decrease) increase in trade payables

Increase (decrease) in other accounts payable and accrued expenses (Decrease) increase in other long-term liabilities

Net cash provided by (used in) operating activities

Cash flows from investing activities:

Capital expenditures Purchase of intangible assets

Investment in marketable securities

Proceeds from maturities of marketable securities Proceeds from sales of marketable securities

Payment related to business combination, net of cash acquired

Short-term deposits, net

Net cash (used in) provided by investing activities

Cash flows from financing activities:

Exercise of warrants, net Exercise of options to shares Proceeds from ESPP, net

Net cash provided by financing activities

Net (decrease) increase in cash and cash equivalents and restricted cash

Net effect of currency translation on cash and cash equivalents

Cash and cash equivalents and restricted cash at beginning of period

8,777 8,810 15,308 11,997

(523) (1,202) (488) (158)

2,631 2,592 2,703 3,941

- - - 554

(2,380) (2,303) (1,734) (1,747)

(386) (1,387) (51) 1,899

- - - -

- - - -

- - - -

1,721 (10,931) (11,225) 4,654

992 2,310 13,310 33,156

785 210 398 (8,329)

5,480 (2,748) 336 2,546

1,156 1,070 1,197 1,162

(1,179) (532) (892) 3,150

- - - 1,760

(10) (524) 882 1,284

(1,046) (166) 713 5,442

(12,152) 17,622 (8,032) 6,810

(388) 286 658 (2,571)

20,878 32,583 33,272 86,811

(2,339) (3,608) (3,322) (3,956)

- - - -(129,956) (53,190) (12,057) (126,028)

27,419 32,204 58,597 34,772

- 31,166 - 28,643

- - - (147,456) (21,628) 34,005 20,570 (32,086)

(126,504) 40,577 63,788 (246,111)

- - - -

2,493 12,624 3,958 1,022

1,127 1,202 1,309 1,318

3,620 13,826 5,267 2,340

(102,006) 86,986 102,327 (156,960)

822 1,762 (189) 56

191,659 90,475 179,223 281,361

14,384 15,249 15,446

(1,148) (237) (732)

7,005 8,915 9,339

- - -

(1,793) (1,736) (1,844)

(750) (15) 70

- - -

- - -

- - -

32,441 (38,070) (29,132)

(20,861) 7,987 33,401

552 (253) (459)

(4,964) 4,351 810

1,055 1,058 1,200

(1,015) (645) (813)

- - 0

144 (859) 878

(5,987) 7,181 2,273

(10,393) 6,898 (1,363)

277 1,394 851

19,885 17,589 56,581

(3,041) (3,068) (4,784)

(7,059) (8,560) -8,470

(74,575) (50,050) (70,826)

24,607 36,338 29,277

39,706 15,840 49,796

(15,278) 0 0

22,065 (4,246) 27,396

(13,575) (13,746) 22,389

- - -

2,128 2,123 1,318

1,383 1,485 1,300

3,511 3,608 2,618

9,821 7,451 81,588

(589) 110 217

124,457 133,689 141,250

Cash and cash equivalents and restricted cash at end of period

$ 90,475 $

179,223

$ 281,361

$ 124,457

$133,689

$ 141,250

$223,055

Supplemental cash flow information:

Income taxes (received) paid

Purchase of property and equipment on suppliers' credit Purchase of intangible assets

Operating lease liabilities arising from obtaining right of use assets Reclassification of warrants from liability to equity

Reclassification of Restricted Sponsor Shares from liability to equity

Reclassification of Price Adjustment Shares from liability to equity

Note: This document should be read in conjunction with the Company's SEC Filings.

$ 806 $

$ - $

$ - $

$ 813 $

$ - $

$ - $

$ - $

(8,879) $

- $

- $

12,328 $

- $

- $

- $

4,686 $

- $

- $

- $

- $

- $

- $

2,838

-

-(1,987)

-

-

-

$ 3,538

$ -

$ -

$ 1,150

$ -

$ -

$ -

$ 6,997

$ -

$ -

$ 1,069

$ -

$ -

$ -

$ 4,622

$ -

$ -

$ 937

$ -

$ -

$ -

FY 2026

FY 2025

FY 2024

FY 2023

Yr Ended

31-Dec

$ 53,231

1,733

-52

$ 51,446

$ 271,879

1,733

-52

$ 273,664

$ 238,642

-(345)

17,265

3,347

(7)

$ 218,382

Yr Ended

31-Dec

$ 62,593

2,227

-

2

$ 60,364

$ 338,610

2,227

-

2

$ 340,839

$ 281,704

1,068

-28,348

3,349

219

$ 248,720

Yr Ended

31-Dec

$ 75,172

3,180

881

-

$ 71,111

$ 400,503

3,180

881

-

$ 404,564

$ 334,023

574

-41,712

4,018

3,818

$ 283,901

YTD

30-Sep

$ 75,602

2,047

15,093

1

$ 58,461

$ 332,859

2,047

15,093

1

$ 350,000

$ 289,916

520

-43,032

4,055

2,230

$ 240,079

Quarter Ended

31-Mar 30-Jun 30-Sep 31-Dec

$ 17,490 $ 17,677 $ 20,314 $ 19,691

750 827 828 775

- - - 881

- - - -

$ 16,740 $ 16,850 $ 19,486 $ 18,035

Quarter Ended

31-Mar 30-Jun 30-Sep

$ 22,420 $ 25,207 $ 27,975

692 657 698

3,612 5,536 5,945

- 1 -

$ 18,116 $ 19,013 $ 21,332

$ 90,059

$ 95,599

$ 105,715

$ 109,130

$ 105,881

$ 105,931

$ 121,047

750

827

828

775

692

657

698

-

-

-

881

3,612

5,536

5,945

-

-

-

-

-

1

-

$ 90,809

$ 96,426

$ 106,543

$ 110,786

$ 110,185

$ 112,125

$ 127,690

$ 77,791

$ 81,182

$ 86,725

$ 88,325

$ 96,762

$ 98,982

$ 94,172

-

-

574

-

-

-

520

-

-

-

-

-

-

-

8,027

7,983

14,480

11,222

13,692

14,592

14,748

926

931

934

1,227

1,362

1,394

1,299

-

2,066

164

1,588

109

676

1,445

$ 68,838

$ 70,202

$ 70,573

$ 74,288

$

81,599

$

82,320

$

76,160

GAAP to Non-GAAP Reconciliations

(U.S. Dollars in thousands, except share and per share data)

GAAP cost of revenue: Cost of revenue Less:

Share-based compensation expense Amortization of intangible assets Acquisition-related costs

Non-GAAP cost of revenue

GAAP gross profit:

Gross profit

Share-based compensation expense Amortization of intangible assets Acquisition-related costs

Non-GAAP gross profit

GAAP operating expenses: Operating expenses Less:

Executive severance costs Issuance expenses

Share-based compensation expense Amortization of intangible assets Acquisition-related costs

Non-GAAP operating expenses

FY 2026

Quarter Ended

31-Mar

30-Jun

30-Sep

31-Dec

31-Mar

Quarter Ended

30-Jun

30-Sep

$ 12,268

-

-8,777

926

-

$ 21,971

$ 14,417 $ 18,990

- 574

- -

8,810 15,308

931 934

2,066 164

$ 26,224 $ 35,970

$ 20,805

-

-11,997

2,108

1,588

$ 36,498

$

$

9,119

-

-14,384

4,974

109

28,586

$

$

6,949

-

-15,249

6,930

677

29,805

$

$

26,875

520

-15,446

7,244

1,445

51,530

$ 17,400

-

-

-

-8,777

926

-(924)

-

$ 26,179

$ 19,476 $ 20,189

- 574

- -

- -

- -

8,810 15,308

931 934

2,066 164

(510) (309)

- -

$ 30,773 $ 36,860

$ 21,261

-

-

-

-11,997

2,108

1,588

(260)

-

$ 36,694

$

$

10,938

-

-

-

-14,384

4,974

109

215

-

30,620

$

$

6,371

-

-

-

-15,249

6,930

677

465

-

29,692

$

$

26,656

520

-

-

-15,446

7,244

1,445

-5,761

-

45,550

$ 17,400

(7,060)

1,928

2,631

-

-8,777

-

$ 23,676

22.0%

$ 19,476 $ 20,189

(6,374) (5,298)

1,315 4,099

2,592 2,703

- 574

- -

8,810 15,308

2,066 164

$ 27,885 $ 37,739

24.6% 29.9%

$ 21,261

(5,466)

5,010

3,941

-

-11,997

1,588

$ 38,331

29.8%

$

$

10,938

(4,515)

2,696

7,005

-

-14,384

109

30,617

23.9%

$

$

6,371

(4,238)

4,816

8,915

-

-15,249

677

31,790

24.2%

$

$

26,656

(4,866)

5,085

9,339

520

-15,446

1,445

53,625

36.0%

20,878

32,583

33,272

86,811

19,885

17,589

56,581

(2,339)

$18,539

(3,608) (3,322) (3,956)

$28,975 $ 29,950 $ 82,855

$

(3,041)

16,844

$

(3,068)

14,521

$

(4,784)

51,797

FY 2025

FY 2024

FY 2023

Yr Ended

31-Dec

$ 33,237

-(345)

18,998

3,347

45

$ 55,282

$ (81,100)

-

-(345)

-18,998

3,347

45

633

119,348

$ 60,926

$ (81,100)

108,800

5,537

10,011

-(345)

18,998

45

$ 61,946

19.1%

102,058

(5,231)

$ 96,827

29.8%

Yr Ended

31-Dec

$ 56,906

1,068

-30,575

3,349

221

$ 92,119

$ (283,007)

1,068

-

-

-30,575

3,349

221

(4,049)

349,604

$ 97,761

$ (283,007)

332,890

7,023

10,607

1,068

-30,575

221

$ 99,377

24.8%

132,171

(8,566)

$ 123,605

30.8%

Yr Ended

31-Dec

$ 66,480

574

-44,892

4,899

3,818

$ 120,663

$ 78,326

574

-

-

-44,892

4,899

3,818

(2,003)

-

$ 130,506

$ 78,326

(24,198)

12,352

11,867

574

-44,892

3,818

$ 127,631

26.8%

173,544

(13,225)

$ 160,319

33.7%

YTD

30-Sep

$ 42,943

520

-45,079

19,148

2,231

$ 109,921

$ 43,965

520

-

-

-45,079

19,148

2,231

-5,081

-

$ 105,862

$ 43,965

(13,619)

12,597

25,259

520

-45,079

2,231

$ 116,032

28.4%

94,055

(10,893)

$ 83,162

20.4%

GAAP to Non-GAAP Reconciliations

(U.S. Dollars in thousands, except share and per share data)

GAAP operating income (loss) Executive severance costs Issuance expenses

Share-based compensation expense Amortization of intangible assets Acquisition-related costs

Non-GAAP operating income (loss)

GAAP net income (loss) Executive severance costs One-time tax income Issuance expenses

Dividend participation compensation Share-based compensation expense Amortization of intangible assets Acquisition related costs

Income tax expense Finance expenses (income)

Non-GAAP net income (loss)

GAAP net income (loss) Financial (Income) expense Tax expense (income)

Depreciation and amortization Executive severance costs Issuance expenses

Share-based compensation expense Acquisition-related costs

Adjusted EBITDA

Adjusted EBITDA margin

Cash flows from operating activities

Less:

Capital expenditures

Free Cash Flow

Free Cash Flow margin

Note: This document should be read in conjunction with the Company's SEC Filings.

17.2% 25.6% 23.8% 64.3%

13.1% 11.1% 34.8%

FY 2026

Quarter Ended

31-Mar

30-Jun

30-Sep

31-Dec

31-Mar

Quarter Ended

30-Jun

30-Sep

FY 2025

FY 2024

FY 2023

Yr Ended

31-Dec

$ 172,154

112,247

40,709

$ 325,110

53.0%

34.5%

12.5%

100.0%

315,689

-

315,689

315,689

165,389

114,206

36,094

125%

Yr Ended

31-Dec

$ 215,531

134,921

50,751

$ 401,203

53.7%

33.6%

12.6%

100.0%

395,899

-395,899

395,899

214,565

134,061

47,273

124%

Yr Ended

31-Dec

$ 256,582

161,361

57,732

$ 475,675

53.9%

33.9%

12.0%

100.0%

480,760

16,078

464,682

480,760

256,380

166,440

57,940

116%

YTD

30-Sep

$ 216,562

137,948

53,951

$ 408,461

-

53.0%

33.8%

13.2%

100.0%

528,452

-

528,452

528,452

280,400

179,651

68,401

116%

Cellebrite DI Ltd. - Revenue Mix

(U.S. Dollars in thousands - unaudited)

Revenue by geography:

Americas

$ 56,531

$ 61,246

$ 72,805

$ 66,000

$ 66,006

$ 69,249

$ 81,307

EMEA APAC

37,421 38,461 38,488 46,991

13,597 13,569 14,736 15,830

46,825 43,300 47,823

15,470 18,589 19,892

Total revenue

$ 107,549

$ 113,276

$ 126,029

$ 128,821

$ 128,301

$ 131,138

$ 149,022

Revenue % of total:

Americas EMEA APAC

Total revenue

Annual recurring revenue (in thousands)

Total ARR

ARR related to acquisitions Organic ARR

Annual recurring revenue (in thousands)

America EMEA APAC

Recurring revenue net dollar-based retention rate

Note: This document should be read in conjunction with the Company's SEC Filings.

52.6% 54.0% 57.8% 51.2%

34.8% 34.0% 30.5% 36.5%

12.6% 12.0% 11.7% 12.3%

100.0% 100.0% 100.0% 100.0%

408,060 418,875 439,803 480,760

- - - 16,078 408,060 418,875 439,803 464,682

408,060 418,875 439,803 480,760

221,259 226,296 240,244 256,380

136,432 141,762 147,200 166,440

50,369 50,817 52,359 57,940

121% 120% 117% 116%

51.4% 52.8% 54.6%

36.5% 33.0% 32.1%

12.1% 14.2% 13.3%

100.0% 100.0% 100.0%

492,970 507,771 528,452

- - -

492,970 507,771 528,452

492,970 507,771 528,452

261,090 267,414 280,400

170,930 175,072 179,651

60,950 65,285 68,401

115% 117% 116%

Cellebrite DI Ltd. on 6ix

Story so far

Earlier from Cellebrite DI

All Cellebrite DI news releases